Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation
Introduction. The world standard for treating muscle-invasive bladder cancer is radical cystectomy with pelvic lymphadenectomy. Several large studies report significant postoperative complications of radical cystectomy. In 2003, a team of urologists led by Mani Menon performed a series of robot-assi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2024-04-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/910 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849394433303248896 |
|---|---|
| author | V. N. Pavlov M. F. Urmantsev M. R. Bakeev |
| author_facet | V. N. Pavlov M. F. Urmantsev M. R. Bakeev |
| author_sort | V. N. Pavlov |
| collection | DOAJ |
| description | Introduction. The world standard for treating muscle-invasive bladder cancer is radical cystectomy with pelvic lymphadenectomy. Several large studies report significant postoperative complications of radical cystectomy. In 2003, a team of urologists led by Mani Menon performed a series of robot-assisted radical cystectomies (RARC) for the first time. Currently, it is possible to evaluate the survival of patients aft er RARC.Aim. To determine the indicators of overall (OS), cancer-specific (CSS), and recurrence-free survival (RFS) aft er RARC with pelvic lymphadenectomy in patients with muscle-invasive bladder cancer that were operated at a single center.Materials and methods. In 2018–2023, 200 patients with muscle-invasive bladder cancer were operated at the Oncology Department of the Bashkir State Medical University Clinic. The operation procedure involved performing RARC with intracorporeal urinary derivation. The maximum follow-up period was limited to 36 months. The survival analysis was performed for the total cohort of patients, as well as following stratification for pN (+/–) status. In order to visualize the obtained results, Kaplan-Meier curves were used.Results and discussion. After 36 months, the survival indicators of all operated patients were as follows: OS — 48.25%; CSS — 57.49%; RFS — 61.89% (p = 0.0031, χ2 = 11.325). Also, a significant decrease in all the survival indicators of pN (+) patients was observed, p < 0.0001. In the pN (+) patient group, patients with advanced pT stage were found to be predominant as compared to the pN (–) group.Conclusion. The analysis of survival after RARC shows satisfactory longterm oncologic outcomes. After RARC, the leading causes of death are regional lymph node involvement and advanced pT stage. |
| format | Article |
| id | doaj-art-c2e722cbd5064010a98b369169d03eb0 |
| institution | Kabale University |
| issn | 2076-3093 2307-0501 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Bashkir State Medical University |
| record_format | Article |
| series | Креативная хирургия и онкология |
| spelling | doaj-art-c2e722cbd5064010a98b369169d03eb02025-08-20T03:39:58ZengBashkir State Medical UniversityКреативная хирургия и онкология2076-30932307-05012024-04-0114151210.24060/2076-3093-2024-14-1-5-12557Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivationV. N. Pavlov0M. F. Urmantsev1M. R. Bakeev2Bashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityIntroduction. The world standard for treating muscle-invasive bladder cancer is radical cystectomy with pelvic lymphadenectomy. Several large studies report significant postoperative complications of radical cystectomy. In 2003, a team of urologists led by Mani Menon performed a series of robot-assisted radical cystectomies (RARC) for the first time. Currently, it is possible to evaluate the survival of patients aft er RARC.Aim. To determine the indicators of overall (OS), cancer-specific (CSS), and recurrence-free survival (RFS) aft er RARC with pelvic lymphadenectomy in patients with muscle-invasive bladder cancer that were operated at a single center.Materials and methods. In 2018–2023, 200 patients with muscle-invasive bladder cancer were operated at the Oncology Department of the Bashkir State Medical University Clinic. The operation procedure involved performing RARC with intracorporeal urinary derivation. The maximum follow-up period was limited to 36 months. The survival analysis was performed for the total cohort of patients, as well as following stratification for pN (+/–) status. In order to visualize the obtained results, Kaplan-Meier curves were used.Results and discussion. After 36 months, the survival indicators of all operated patients were as follows: OS — 48.25%; CSS — 57.49%; RFS — 61.89% (p = 0.0031, χ2 = 11.325). Also, a significant decrease in all the survival indicators of pN (+) patients was observed, p < 0.0001. In the pN (+) patient group, patients with advanced pT stage were found to be predominant as compared to the pN (–) group.Conclusion. The analysis of survival after RARC shows satisfactory longterm oncologic outcomes. After RARC, the leading causes of death are regional lymph node involvement and advanced pT stage.https://www.surgonco.ru/jour/article/view/910muscle-invasive bladder cancerrobot-assisted radical cystectomypelvic lymphadenectomyoncologic outcomessurvival analysisintracorporeal urinary derivation |
| spellingShingle | V. N. Pavlov M. F. Urmantsev M. R. Bakeev Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation Креативная хирургия и онкология muscle-invasive bladder cancer robot-assisted radical cystectomy pelvic lymphadenectomy oncologic outcomes survival analysis intracorporeal urinary derivation |
| title | Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation |
| title_full | Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation |
| title_fullStr | Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation |
| title_full_unstemmed | Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation |
| title_short | Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation |
| title_sort | survival in patients with muscle invasive bladder cancer after robot assisted radical cystectomy with intracorporeal urinary derivation |
| topic | muscle-invasive bladder cancer robot-assisted radical cystectomy pelvic lymphadenectomy oncologic outcomes survival analysis intracorporeal urinary derivation |
| url | https://www.surgonco.ru/jour/article/view/910 |
| work_keys_str_mv | AT vnpavlov survivalinpatientswithmuscleinvasivebladdercancerafterrobotassistedradicalcystectomywithintracorporealurinaryderivation AT mfurmantsev survivalinpatientswithmuscleinvasivebladdercancerafterrobotassistedradicalcystectomywithintracorporealurinaryderivation AT mrbakeev survivalinpatientswithmuscleinvasivebladdercancerafterrobotassistedradicalcystectomywithintracorporealurinaryderivation |